1. Home
  2. NMP vs BIOA Comparison

NMP vs BIOA Comparison

Compare NMP & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMP
  • BIOA
  • Stock Information
  • Founded
  • NMP 2024
  • BIOA 2015
  • Country
  • NMP United States
  • BIOA United States
  • Employees
  • NMP N/A
  • BIOA N/A
  • Industry
  • NMP Blank Checks
  • BIOA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NMP Finance
  • BIOA Health Care
  • Exchange
  • NMP Nasdaq
  • BIOA Nasdaq
  • Market Cap
  • NMP 158.8M
  • BIOA 175.7M
  • IPO Year
  • NMP 2025
  • BIOA 2024
  • Fundamental
  • Price
  • NMP $10.00
  • BIOA $7.52
  • Analyst Decision
  • NMP
  • BIOA Hold
  • Analyst Count
  • NMP 0
  • BIOA 4
  • Target Price
  • NMP N/A
  • BIOA $7.33
  • AVG Volume (30 Days)
  • NMP 42.9K
  • BIOA 575.1K
  • Earning Date
  • NMP 01-01-0001
  • BIOA 11-06-2025
  • Dividend Yield
  • NMP N/A
  • BIOA N/A
  • EPS Growth
  • NMP N/A
  • BIOA N/A
  • EPS
  • NMP N/A
  • BIOA N/A
  • Revenue
  • NMP N/A
  • BIOA $3,863,000.00
  • Revenue This Year
  • NMP N/A
  • BIOA N/A
  • Revenue Next Year
  • NMP N/A
  • BIOA N/A
  • P/E Ratio
  • NMP N/A
  • BIOA N/A
  • Revenue Growth
  • NMP N/A
  • BIOA N/A
  • 52 Week Low
  • NMP $9.90
  • BIOA $2.88
  • 52 Week High
  • NMP $10.00
  • BIOA $25.33
  • Technical
  • Relative Strength Index (RSI)
  • NMP N/A
  • BIOA 71.06
  • Support Level
  • NMP N/A
  • BIOA $5.05
  • Resistance Level
  • NMP N/A
  • BIOA $8.60
  • Average True Range (ATR)
  • NMP 0.00
  • BIOA 0.37
  • MACD
  • NMP 0.00
  • BIOA 0.19
  • Stochastic Oscillator
  • NMP 0.00
  • BIOA 68.31

About NMP NMP Acquisition Corp. Class A Ordinary Shares

NMP Acquisition Corp is a blank check company.

About BIOA BioAge Labs Inc. Common Stock

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Share on Social Networks: